Basics Acrivon Therapeutics, Inc. IPO Date: November 15, 2022 Sector: Healthcare Industry: Biotech Market Cap: $41.84M Activated in VL: True Average Daily Range Avg Daily Range: $0.32 | 3.99% Avg Daily Range (30 D): $0.04 | 2.62% Avg Daily Range (90 D): $0.04 | 2.93% Institutional Daily Volume Avg Daily Volume: .17M Avg Daily Volume (30 D): .36M Avg Daily Volume (90 D): .42M Trade Size Avg Trade Size (Sh.): 107 Avg Trade Size (Sh.) (30 D): 202 Avg Trade Size (Sh.) (90 D): 215 Institutional Trades Total Inst.Trades: 20 Avg Inst. Trade: $2.29M Avg Inst. Trade (30 D): $1.11M Avg Inst. Trade (90 D): $.83M Avg Inst. Trade Volume: .22M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.11M Avg Closing Trade (30 D): $1.11M Avg Closing Trade (90 D): $.83M Avg Closing Volume: 320.84K     News Jul 15, 2025 @ 5:00 PM Endometrial Cancer Clinical Trial Pipeline Insight... Source: Delveinsight Sep 14, 2024 @ 7:10 AM Acrivon Therapeutics Reports Positive Endometrial ... Source: N/A Jul 10, 2024 @ 1:01 PM Athira (ATHA) Completes Dosing in Alzheimer's Stud... Source: N/A Jul 5, 2024 @ 1:31 PM AstraZeneca's (AZN) Tagrisso Gets EU Nod for First... Source: N/A Jul 2, 2024 @ 4:12 PM SpringWorks (SWTX) Completes NDA Submission for Mi... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-2.21 $-.51 $-.59 Diluted EPS $-2.21 $-.51 $-.59 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -83.75M $ -19.68M $ -22.83M Operating Income / Loss $ -93.19M $ -21.66M $ -24.95M Cost of Revenue $ $ $ Net Cash Flow $ 14.33M $ -.66M $ -3.6M PE Ratio